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Purpose of the study
Antiretroviral (ARV) therapy is currently associated with
longer survival and improved quality of life in AIDS
patients. Several complications related to these drugs have
been recently published, specifically thrombotic events.
Hyperhomocysteinemia is an independent risk factor for
atherothrombosis and venous thrombosis. Therefore, we
aimed to determine the effect of ARV therapy on homo-
cysteine plasma levels in patients with AIDS.
Methods
We included adult patients with HIV-infection naive for
ARV drugs. ARV regimens were selected by the attending
physician according to the DHHS Adult and Adolescents
Treatment Guidelines criteria. Before and after 6 months
of ARV treatment, we evaluated fasting and post oral
methionine load (OML) plasma homocysteine, vitamins
B6 and B12, and intra-erythrocyte and serum folate levels.
Summary of results
We studied 69 AIDS patients who started ARV therapy
during a 6-month period (Table 1). Mean fasting homo-
cysteine levels increased significantly with respect to basal
values (p < 0.001) although hyperhomocysteinemia was
present in 12.8% and 14.2% of patients before and after
treatment (p = 0.7). As compared with basal values, post-
OML homocysteine increased significantly after 6 months
of therapy (p < 0.001) and post-OML hyperhomo-
cysteinemia was present in 34.2% and 94.2% of patients
before and after ARV treatment (p = 0.001). Plasma
homocysteine, either fasting or post-OML, rose after 6
months of treatment independently of the ARV regimen.
Conclusion
Hyperhomocysteinemia, mostly that uncovered post-
OML, is a frequent condition associated with ARV treat-
ment.
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Table 1: Serum concentrations of vitamins B6 and B12, serum and intra-erythrocyte folate levels, and plasma homocysteine 
concentrations in patients with AIDS before and 6 months after ARV therapy.
Before ARV After 6-months ARV P
Variable Mean SD Mean SD
Vitamin B6 (pg/mL) 51.28 24.08 49.5 19.04 0.80
Vitamin B12 (pg/mL) 875.89 491.38 891.92 471.71 0.79
Serum folic acid (ng/mL) 5.89 2.31 4.96 1.51 0.008
Intra-erythrocyte folate (ng/mL) 365.9 131.19 316 77.27 0.013
Fasting homocysteine (micromol/L) 7.92 3.40 9.02 2.96 0.001
Post-OML homocysteine (micromol/L) 24.88 14.63 36.09 16.17 0.001Page 2 of 2
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